Marius Pharmaceuticals is pleased to announce that Thrive, a leading provider of personalized healthcare solutions and a trusted partner of O2 Fitness, now offers KYZATREX® (testosterone undecanoate) CIII capsules to its patients nationwide....
Centinel Spine®, LLC the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world...
Hoth Therapeutics, Inc. a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its collaboration with OnTargetx R&D Inc. to advance research for its cancer-fighting therapeutic, HT-KIT....
Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette’s...
Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health. Highmark’s commercial members across Pennsylvania, West Virginia, Delaware,...
Jabil Inc. a global leader in engineering, manufacturing, and supply chain solutions, announced the successful acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in...
Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare,...
Harbour BioMed a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, announced that the National Medical Products Administration...
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces today the appointment of Abdelghani (Abdel) Omari as its first-ever...
HOOKIPA Pharma Inc. a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced that enrollment is complete in the Phase 1b clinical trial...
Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of chemotherapy drugs'...
Azenta, Inc. announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of...
NLS Pharmaceutics Ltd. a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous system disorders, and Kadimastem Ltd. ("Kadimastem") (TASE: KDST), a...
PharmaScroll, a premier market research and business analytics firm, continues to set the benchmark for excellence in supporting the global life sciences and healthcare organizations. Renowned for its innovative tech-based solutions and in-depth...
Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technologies, announces the launch of the Alto Automation Suite™ for its flagship Alto™ Digital SPR™ system. This makes Alto the world’s first SPR platform...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom...
Beacon Therapeutics Holdings Limited a leading ophthalmic gene therapy company with a mission to save and restore the vision of patients with blinding retinal diseases, announced that the U.S. Food and Drug Administration (FDA) has granted...
Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, announced that it has secured a $30 million financing to advance the development of LUT014, an...
Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), today...
West Pharmaceutical Services, Inc. a global leader in innovative solutions for injectable drug administration, announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple...